BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 34363037)

  • 21. Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.
    Yamanouchi M; Furuichi K; Hoshino J; Toyama T; Hara A; Shimizu M; Kinowaki K; Fujii T; Ohashi K; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Hisano S; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Mise K; Makino H; Matsuo S; Ubara Y; Wada T;
    Diabetes Care; 2019 May; 42(5):891-902. PubMed ID: 30833372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'Progressive diabetic nephropathy. How useful is microalbuminuria?: contra'.
    MacIsaac RJ; Ekinci EI; Jerums G
    Kidney Int; 2014 Jul; 86(1):50-7. PubMed ID: 24717301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 diabetes albuminuric and non-albuminuric phenotypes have different morphological and functional ultrasound features of diabetic kidney disease.
    Garofolo M; Napoli V; Lucchesi D; Accogli S; Mazzeo ML; Rossi P; Neri E; Del Prato S; Penno G
    Diabetes Metab Res Rev; 2023 Jan; 39(1):e3585. PubMed ID: 36273390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal function and structure in albuminuric type 2 diabetic patients without retinopathy.
    Christensen PK; Larsen S; Horn T; Olsen S; Parving HH
    Nephrol Dial Transplant; 2001 Dec; 16(12):2337-47. PubMed ID: 11733625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperfiltration in Indigenous Australians with and without diabetes.
    Ekinci EI; Hughes JT; Chatfield MD; Lawton PD; Jones GR; Ellis AG; Cass A; Thomas M; MacIsaac RJ; O'Dea K; Jerums G; Maple-Brown LJ
    Nephrol Dial Transplant; 2015 Nov; 30(11):1877-84. PubMed ID: 26142395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults.
    Tsaryk I; Pashkovska N
    J Med Life; 2022 Jun; 15(6):792-796. PubMed ID: 35928354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data.
    Afkarian M; Polsky S; Parsa A; Aronson R; Caramori ML; Cherney DZ; Crandall JP; de Boer IH; Elliott TG; Galecki AT; Goldfine AB; Haw JS; Hirsch IB; Karger AB; Lingvay I; Maahs DM; McGill JB; Molitch ME; Perkins BA; Pop-Busui R; Pragnell M; Rosas SE; Rossing P; Senior P; Sigal RJ; Spino C; Tuttle KR; Umpierrez GE; Wallia A; Weinstock RS; Wu C; Mauer M; Doria A;
    Diabetes Care; 2019 Aug; 42(8):1454-1463. PubMed ID: 31186299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased risk of renal deterioration associated with low e-GFR in type 2 diabetes mellitus only in albuminuric subjects.
    Meguro S; Shigihara T; Kabeya Y; Tomita M; Atsumi Y
    Intern Med; 2009; 48(9):657-63. PubMed ID: 19420810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Non-Classical Clinical Types and Pathological Changes of Diabetic Kidney Disease: A Review].
    Fang C; Sun L; Liu Y; Xiao L; Sun L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1074-1079. PubMed ID: 38162079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N; Russell J; El Nahas M
    Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
    Shahni R; Gnudi L; King A; Jones P; Malik AN
    Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical predictive factors in diabetic kidney disease progression.
    Radcliffe NJ; Seah JM; Clarke M; MacIsaac RJ; Jerums G; Ekinci EI
    J Diabetes Investig; 2017 Jan; 8(1):6-18. PubMed ID: 27181363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annual deterioration of renal function in hypertensive patients with and without diabetes.
    Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S
    Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.
    Cid Ruzafa J; Paczkowski R; Boye KS; Di Tanna GL; Sheetz MJ; Donaldson R; Breyer MD; Neasham D; Voelker JR
    Int J Clin Pract; 2015 Aug; 69(8):871-82. PubMed ID: 26011029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).
    Yokoyama H; Araki SI; Kawai K; Yamazaki K; Shirabe SI; Sugimoto H; Minami M; Miyazawa I; Maegawa H;
    Diabetes Care; 2020 May; 43(5):1102-1110. PubMed ID: 32144168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.
    Ceriello A; De Cosmo S; Rossi MC; Lucisano G; Genovese S; Pontremoli R; Fioretto P; Giorda C; Pacilli A; Viazzi F; Russo G; Nicolucci A;
    Diabetes Obes Metab; 2017 Nov; 19(11):1570-1578. PubMed ID: 28432733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glomerular hyperfiltration and increased glomerular filtration surface are associated with renal function decline in normo- and microalbuminuric type 2 diabetes.
    Moriya T; Tsuchiya A; Okizaki S; Hayashi A; Tanaka K; Shichiri M
    Kidney Int; 2012 Mar; 81(5):486-93. PubMed ID: 22157655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    J Nephrol; 2020 Feb; 33(1):9-35. PubMed ID: 31576500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1127-1150. PubMed ID: 31586514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of chronic kidney disease and associated factors in Chinese individuals with type 2 diabetes: Cross-sectional study.
    Guo K; Zhang L; Zhao F; Lu J; Pan P; Yu H; Bao Y; Chen H; Jia W
    J Diabetes Complications; 2016 Jul; 30(5):803-10. PubMed ID: 27068269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.